Mo-99 supply updates

Cardinal Health is dedicated to providing the latest information on the limited production of Molybdenum (Mo-99), the key isotope used in the production of technetium (Tc99m). As the global shortage continues, please visit our web site regularly to find the latest news and updates on the supply situation. We understand the major impact the shortage has on the nuclear medicine industry’s ability to effectively diagnose and treat patients on a daily basis. We are actively working with our manufacturers and other global partners to find immediate and long-term solutions to this ongoing crisis.

Latest Mo-99 supply news

»Cardinal Health estimates Technetium-99 (Tc-99m) availability for the rest of September and moving forward as follows:

 

Read more about the shortage, and view estimated Tc-99m availability

---

Suggestions to maintain patient scheduling during the Mo-99 shortage

»Because the supply shortage is a worldwide problem, nuclear pharmacy providers and all hospitals and clinics are being asked to take measures to conserve supply. Additionally, the advanced warnings of these planned shutdowns have helped the industry prepare for the shortages by discovering alternative methods of meeting demands. Read more about alternative measures you can take in your department.

• Use Tl-201 thallous chloride (Thallium)
• Implement Stress-only Scanning
• Decrease patient dosage
• Shift Tc-99m unit dosage calibration/delivery times
• Adjust patient schedules
• Communicate Frequently

---

Additional resources

Find additional Cardinal Health sponsored events, CE solutions courses and other materials to help you stay informed on the Mo-99 shortage. Also, find additional industry news from other nuclear medicine organizations.

---